188 related articles for article (PubMed ID: 32429395)
1. Feasibility of Targeting Traf2-and-Nck-Interacting Kinase in Synovial Sarcoma.
Sekita T; Yamada T; Kobayashi E; Yoshida A; Hirozane T; Kawai A; Uno Y; Moriyama H; Sawa M; Nagakawa Y; Tsuchida A; Matsumoto M; Nakamura M; Nakayama R; Masuda M
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32429395
[TBL] [Abstract][Full Text] [Related]
2. Emergence of TNIK inhibitors in cancer therapeutics.
Yamada T; Masuda M
Cancer Sci; 2017 May; 108(5):818-823. PubMed ID: 28208209
[TBL] [Abstract][Full Text] [Related]
3. TNIK inhibition abrogates colorectal cancer stemness.
Masuda M; Uno Y; Ohbayashi N; Ohata H; Mimata A; Kukimoto-Niino M; Moriyama H; Kashimoto S; Inoue T; Goto N; Okamoto K; Shirouzu M; Sawa M; Yamada T
Nat Commun; 2016 Aug; 7():12586. PubMed ID: 27562646
[TBL] [Abstract][Full Text] [Related]
4. The Traf2 and NcK interacting kinase inhibitor NCB-0846 suppresses seizure activity involving the decrease of GRIA1.
Wang M; Gu Y; Li Q; Feng B; Lv X; Zhang H; Kong Q; Dong Z; Tian X; Zhang Y
Genes Dis; 2024 May; 11(3):100997. PubMed ID: 38292191
[TBL] [Abstract][Full Text] [Related]
5. Traf2- and Nck-interacting kinase (TNIK) is involved in the anti-cancer mechanism of dovitinib in human multiple myeloma IM-9 cells.
Chon HJ; Lee Y; Bae KJ; Byun BJ; Kim SA; Kim J
Amino Acids; 2016 Jul; 48(7):1591-9. PubMed ID: 26995282
[TBL] [Abstract][Full Text] [Related]
6. Direct conversion of osteosarcoma to adipocytes by targeting TNIK.
Hirozane T; Masuda M; Sugano T; Sekita T; Goto N; Aoyama T; Sakagami T; Uno Y; Moriyama H; Sawa M; Asano N; Nakamura M; Matsumoto M; Nakayama R; Kondo T; Kawai A; Kobayashi E; Yamada T
JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33400690
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancer.
Masuda M; Sawa M; Yamada T
Pharmacol Ther; 2015 Dec; 156():1-9. PubMed ID: 26542362
[TBL] [Abstract][Full Text] [Related]
8. Traf2 and NCK Interacting Kinase Is a Critical Regulator of Procollagen I Trafficking and Hepatic Fibrogenesis in Mice.
Buchl SC; Hanquier Z; Haak AJ; Thomason YM; Huebert RC; Shah VH; Maiers JL
Hepatol Commun; 2022 Mar; 6(3):593-609. PubMed ID: 34677004
[TBL] [Abstract][Full Text] [Related]
9. Synergistic inhibition effect of TNIK inhibitor KY-05009 and receptor tyrosine kinase inhibitor dovitinib on IL-6-induced proliferation and Wnt signaling pathway in human multiple myeloma cells.
Lee Y; Jung JI; Park KY; Kim SA; Kim J
Oncotarget; 2017 Jun; 8(25):41091-41101. PubMed ID: 28467797
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological blockage of transforming growth factor-β signalling by a Traf2- and Nck-interacting kinase inhibitor, NCB-0846.
Sugano T; Masuda M; Takeshita F; Motoi N; Hirozane T; Goto N; Kashimoto S; Uno Y; Moriyama H; Sawa M; Nagakawa Y; Tsuchida A; Seike M; Gemma A; Yamada T
Br J Cancer; 2021 Jan; 124(1):228-236. PubMed ID: 33244122
[TBL] [Abstract][Full Text] [Related]
11. Jatrorrhizine inhibits mammary carcinoma cells by targeting TNIK mediated Wnt/β-catenin signalling and epithelial-mesenchymal transition (EMT).
Sun Y; Gao X; Wu P; Wink M; Li J; Dian L; Liang Z
Phytomedicine; 2019 Oct; 63():153015. PubMed ID: 31302315
[TBL] [Abstract][Full Text] [Related]
12. SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma.
Trautmann M; Sievers E; Aretz S; Kindler D; Michels S; Friedrichs N; Renner M; Kirfel J; Steiner S; Huss S; Koch A; Penzel R; Larsson O; Kawai A; Tanaka S; Sonobe H; Waha A; Schirmacher P; Mechtersheimer G; Wardelmann E; Büttner R; Hartmann W
Oncogene; 2014 Oct; 33(42):5006-16. PubMed ID: 24166495
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the ERG-regulated Kinome in Prostate Cancer Identifies TNIK as a Potential Therapeutic Target.
Lee RS; Zhang L; Berger A; Lawrence MG; Song J; Niranjan B; Davies RG; Lister NL; Sandhu SK; Rubin MA; Risbridger GP; Taylor RA; Rickman DS; Horvath LG; Daly RJ
Neoplasia; 2019 Apr; 21(4):389-400. PubMed ID: 30901730
[TBL] [Abstract][Full Text] [Related]
14. TNIK Inhibition Sensitizes TNIK-Overexpressing Lung Squamous Cell Carcinoma to Radiotherapy.
Nguyen T; Carrieri FA; Connis N; Lafargue A; Chang J; Chan A; Shetty AC; Song Y; Hoang T; Jagtap S; Chowdhury DD; Khan MA; Gabrielson KL; Rezaee M; Torres-Ayuso P; Brognard J; Hann CL; Tran PT
Mol Cancer Ther; 2024 Jun; ():OF1-OF11. PubMed ID: 38853421
[TBL] [Abstract][Full Text] [Related]
15. Structural Insight into TNIK Inhibition.
Kukimoto-Niino M; Shirouzu M; Yamada T
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361804
[TBL] [Abstract][Full Text] [Related]
16. TNIK inhibition sensitizes TNIK-overexpressing lung squamous cell carcinoma to radiotherapy.
Nguyen T; Carrieri FA; Connis N; Lafargue A; Chang J; Chan A; Shetty AC; Song Y; Hoang T; Jagtap S; Chowdhury DD; Khan MA; Gabrielson KL; Rezaee M; Torres-Ayuso P; Brognard J; Hann CL; Tran PT
Mol Cancer Ther; 2024 Apr; ():. PubMed ID: 38670554
[TBL] [Abstract][Full Text] [Related]
17. Traf2- and Nck-interacting kinase is essential for Wnt signaling and colorectal cancer growth.
Shitashige M; Satow R; Jigami T; Aoki K; Honda K; Shibata T; Ono M; Hirohashi S; Yamada T
Cancer Res; 2010 Jun; 70(12):5024-33. PubMed ID: 20530691
[TBL] [Abstract][Full Text] [Related]
18. TNIK influence the effects of antipsychotics on Wnt/β-catenin signaling pathway.
Yuan R; Li Y; Fu Y; Ning A; Wang D; Zhang R; Yu S; Xu Q
Psychopharmacology (Berl); 2021 Nov; 238(11):3283-3292. PubMed ID: 34350475
[TBL] [Abstract][Full Text] [Related]
19. The essential role of TNIK gene amplification in gastric cancer growth.
Yu DH; Zhang X; Wang H; Zhang L; Chen H; Hu M; Dong Z; Zhu G; Qian Z; Fan J; Su X; Xu Y; Zheng L; Dong H; Yin X; Ji Q; Ji J
Oncogenesis; 2014 Feb; 2(2):e89. PubMed ID: 24566388
[TBL] [Abstract][Full Text] [Related]
20. Targeting the Wnt signaling pathway in colorectal cancer.
Sawa M; Masuda M; Yamada T
Expert Opin Ther Targets; 2016; 20(4):419-29. PubMed ID: 26439805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
